2024-01-23 20:08:46
MIAMI, March 20, 2021 /PRNewswire/ — Membrane Labs, Inc., a leading digital asset management software company, announces the launch of its next-generation derivatives management platform. The platform enables seamless end-to-end management of OTC derivatives transactions, including ongoing portfolio-level collateral management and trade flow settlement. The platform redefines derivatives trading management in the digital asset space for institutions by solving operational efficiency and risk management issues while providing a best-in-class OTC trading experience. The first trading on the platform took place earlier this week between two industry leaders, XBTO and Arbelos Markets, using Membrane’s end-to-end infrastructure.
“Customers see Membrane’s platform as a game-changer in the digital assets space,” said Carson Cook, CEO of Membrane. “Our technology streamlines derivatives trading and counterparty risk management on a single platform. In collaboration with XBTO and Arbelos, we have “We have set new standards for institutional access to capital markets and portfolio management. Membrane’s platform increases the security and efficiency of the crypto OTC market.”
Mike Geraci, Head of Derivatives at Membrane, said: “Membrane unlocks the true potential of the OTC derivatives market and solves ecosystem fragmentation by providing an integrated toolset for direct market access, settlement, custom pairs and valuations, and collateral management. Given this infrastructure, we expect OTC markets to continue to develop through high trading volume and liquidity.”
Arbelos Markets is a leading trading firm specializing in derivatives from “High Touch” to “Programmatic”. Joshua Lim, CEO of Arbelos, also highlighted the impact of the platform: “Membrane’s platform addresses several critical challenges in our industry. The seamless integration of booking, managing collateral with smart contracts and executing trades, coupled with advanced margin capabilities, is a smart approach to crypto derivatives trading. This is an important step in reducing operational risks and improving our company’s trading efficiency.” Shiliang Tang, President of Arbelos, added: “Easy updating of margin requirements and collateral movements with improved visibility through Membrane has significantly improved our operational processes simplified. It has also brought a level of transparency to the bilateral derivatives landscape that has been sorely lacking in the industry. We look forward to continuing to set new standards in the future.”
Founded in 2015, XBTO provides a broad digital asset platform and tailored investment solutions for sophisticated investors and institutions outside the US. Paul Eisma, Head of Options and Trading at Membrane has developed state-of-the-art institutional OTC options tools that cover every aspect of the trading lifecycle, including collateral and margin management, RFQ, settlement and reporting.”
About Membrane Labs
Membrane is a software infrastructure provider for enterprise-grade capital markets access, integrated with a non-custodial settlement network for OTC spot trades, loans, derivatives and related collateral management with fully customizable reporting.
Photo – https: //mma.prnewswire.com/media/2323831/Membrane_overview_diagram.jpg
Questions & Contact:
Michelle Obine,
marketing@membranelabs.com
1706054704
#Membranes #stateoftheart #digital #asset #derivatives #platform #supports #firstever #OTC #trading #XBTO #Arbelos
